US 11220488
Crystalline polymorph of Ponesimod
granted A61KA61K31/426A61P
Quick answer
US patent 11220488 (Crystalline polymorph of Ponesimod) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/426, A61P, A61P17/06, A61P25/14